Protein detail

ICOS

Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278)

Entry name
ICOS
UniProt ID
EVMP confidence score
0.38
Supporting publications (n)
5
Transmembrane count
1
Protein classification
CD markersDisease related genesHuman disease related genesPredicted membrane proteins
EVMP confidence score

Annotation confidence score; open for threshold definitions.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
Basic Information13
Protein Names
Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278)
Protein Class (4)
CD markersDisease related genesHuman disease related genesPredicted membrane proteins
Protein Function (3)
  • Human disease related genes:Immune system diseases:Primary immunodeficiency
  • Disease related genes
  • CD markers
Transmembrane
141..161; Helical
Transmembrane Count
1
Entrez Gene Symbol
Gene Synonym (2)
AILIMCD278
Gene Description
Inducible T cell costimulator
Chromosome
2
Position
203936763-203961577
Supporting publications (n)
5
EVMP confidence score
0.38
Fluorescence & Localization1
ICOS fluorescence
Function & Pathway6
Relations & Evidence63

Ligand-Receptor Signaling (46)

46 records.

CategoryParentDatabaseTransmitterReceiverSecretedPlasma Membrane (Transmembrane)Plasma Membrane (Peripheral)
transmembrane_predictedtransmembraneOmniPathNoNoYesYesNo
transmembranetransmembraneCellPhoneDBNoNoYesYesNo
transmembranetransmembraneTopDBNoNoYesYesNo
transmembranetransmembraneRamilowski_locationNoNoYesYesNo
transmembranetransmembraneOmniPathNoNoYesYesNo
plasma_membraneplasma_membraneUniProt_locationNoNoYesYesNo
plasma_membraneplasma_membraneCellinkerNoNoYesYesNo
plasma_membraneplasma_membraneOmniPathNoNoYesYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneMembranomeNoNoYesYesNo
plasma_membrane_transmembraneplasma_membrane_transmembraneOmniPathNoNoYesYesNo
Page 3 of 5PreviousNext

Regulatory Interaction Network (2)

2 records.

Protein Complex Composition (14)

14 records.

Page 2 of 2Previous

Isolation & Detection Technology (1)

1 record.

EV Isolation MethodDetection MethodNumber of ReferencesReferences
Differential UltracentrifugationSize Exclusion ChromatographyMass spectrometry [LTQ-FT Ultra]Mass spectrometry138716512
Sequence, Structure & Domains9

Sequences

Length
199
Mass
22,625
Sequence
MKSGLWYFFLFCLRIKVLTGEINGSANYEMFIFHNGGVQILCKYPDIVQQFKMQLLKGGQILCDLTKTKGSGNTVSIKSLKFCHSQLSNNSVSFFLYNLDHSHANYYFCNLSIFDPPPFKVTLTGGYLHIYESQLCCQLKFWLPIGCAAFVVVCILGCILICWLTKKKYSSSVHDPNGEYMFMRAVNTAKKSRLTDVTL
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=Q9Y6W8-1; Sequence=Displayed; Name=2; IsoId=Q9Y6W8-2; Sequence=VSP_010788
Alternative Sequence
168..199; KYSSSVHDPNGEYMFMRAVNTAKKSRLTDVTL -> M (in isoform 2)

3D Structural Models

Helix
101..103
Beta Strand
31..33; 35..43; 50..57; 60..69; 75..78; 84..87; 89..96; 106..118; 120..127
3D Structure
X-ray crystallography (2)

Domain & Motif Annotations

Domain (FT)
30..132; Ig-like V-type
Clinical Relevance7
Biomarker
Phase 1; Phase 2
Interaction Protein
ENSG00000160223
Interaction Count
1
Interaction Dataset
intact_biogrid
Supporting Publications5
PMIDTitleAbstract
24505114Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscan™) platform.These included proteins of known association with cancer exosomes such as MFG-E8, integrins, and MET, and also those less widely reported as exosomally associated, such as ROR1 and ITIH4.
31588238Dual-platform affinity proteomics identifies links between the recurrence of ovarian carcinoma and proteins released into the tumor microenvironment.No abstract available
32231660Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors.No abstract available
38490958Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer.No abstract available
38731868The Deep Proteomics Approach Identified Extracellular Vesicular Proteins Correlated to Extracellular Matrix in Type One and Two Endometrial Cancer.No abstract available